Stay updated on Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe history now shows a new entry for Revision: v3.5.2 and the previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3 from the page.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision v3.4.3 was added and Revision v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check83 days agoChange DetectedAdded a site-wide funding notice to the page. Introduced a new revision entry (v3.4.1) in the record history, and removed the previous revision (v3.4.0).SummaryDifference0.7%

- Check90 days agoChange DetectedAdded a glossary display and color-coded highlights to indicate additions and deletions. Removed the No FEAR Act data entry and updated the revision label to v3.4.0.SummaryDifference0.9%

Stay in the know with updates to Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.